Millipore Sigma Vibrant Logo

569397 Staurosporine, Streptomyces sp.

Staurosporine, CAS 62996-74-, is a cell-permeable, potent, reversible, ATP-competitive inhibitor of protein kinases (IC₅₀ = 7, 20, 1.3, 0.7, & 8.5 nM for PKA, CAMK, MLCK, PKC, & PKG, respectively).

Staurosporine, Streptomyces sp.: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: MLCK Inhibitor I, PKA Inhibitor II

Primary Target: PKA
View Products on Sigmaaldrich.com
569397
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
62996-74-1C₂₈H₂₆N₄O₃

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
569397-100UG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 100 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      569397-1MG
      Comprobando disponibilidad...
      —
      Disponibilidad a confirmar Disponibilidad a confirmar
      Ingrese cantidad 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          		 Ampolla de plást. 1 mg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Maximum Quantity is
          Al finalizar el pedido Más información
          Ahorró ()
           
          —
          Solicitar precio
          		 —
          569397-250UG
          Comprobando disponibilidad...
          —
          Disponibilidad a confirmar Disponibilidad a confirmar
          Ingrese cantidad 
          Suspendido
          Cantidades limitadas disponibles
          Debe confirmarse disponibilidad
            El resto: se avisará
              El resto: se avisará
              Se avisará
              Póngase en contacto con el Servicio de Atención al Cliente
              Contact Customer Service

              		 Ampolla de plást. 250 μg
              Recuperando precio...
              No pudo obtenerse el precio
              La cantidad mínima tiene que ser múltiplo de
              Maximum Quantity is
              Al finalizar el pedido Más información
              Ahorró ()
               
              —
              Solicitar precio
              		 —
              Description
              OverviewA potent, cell-permeable, reversible, ATP-competitive and broad spectrum inhibitor of protein kinases. Inhibits protein kinase A (IC50 = 7 nM), CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase C (IC50 = 700 pM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint. A 1 mM (100 µg/214 µl) solution of Staurosporine (Cat. No. 569396) in DMSO is also available.
              Catalogue Number569397
              Brand Family Calbiochem®
              SynonymsMLCK Inhibitor I, PKA Inhibitor II
              References
              ReferencesCouldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
              Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
              Bruno, S., et al. 1992. Cancer Res. 52, 470.
              Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
              Vitale, M.L., et al. 1992. Neuroscience 51, 463.
              Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
              Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.
              Product Information
              CAS number62996-74-1
              ATP CompetitiveY
              FormWhite to pale yellow solid
              Hill FormulaC₂₈H₂₆N₄O₃
              Chemical formulaC₂₈H₂₆N₄O₃
              ReversibleY
              Structure formula ImageStructure formula Image
              Quality LevelMQ100
              Applications
              Biological Information
              Primary TargetPKA
              Primary Target IC<sub>50</sub>7 nM, 20 nM, 1.3 nM, 700 pM, and 8.5 nM against protein kinase A , CaM kinase, myosin light chain kinase, protein kinase C, and protein kinase G, respectively
              Purity≥99% by HPLC
              Physicochemical Information
              Cell permeableY
              Dimensions
              Materials Information
              Toxicological Information
              Safety Information according to GHS
              Safety Information
              Product Usage Statements
              Storage and Shipping Information
              Ship Code Ambient Temperature Only
              Toxicity Standard Handling
              Storage +2°C to +8°C
              Protect from Light Protect from light
              Do not freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
              Packaging Information
              Packaged under inert gas Packaged under inert gas
              Transport Information
              Supplemental Information
              Specifications
              Global Trade Item Number
              Número de referencia GTIN
              569397-100UG 07790788057855
              569397-1MG 04055977190465
              569397-250UG 04055977190496

              Documentation

              Staurosporine, Streptomyces sp. Ficha datos de seguridad (MSDS)

              Título

              Ficha técnica de seguridad del material (MSDS) 

              Staurosporine, Streptomyces sp. Certificados de análisis

              CargoNúmero de lote
              569397

              Referencias bibliográficas

              Visión general referencias
              Couldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
              Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
              Bruno, S., et al. 1992. Cancer Res. 52, 470.
              Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
              Vitale, M.L., et al. 1992. Neuroscience 51, 463.
              Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
              Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.

              Folleto

              Cargo
              Caspases and other Apoptosis Related Tools Brochure
              Protein Kinase Assay and Detection Kits Brochure
              Tools and Tips for Analyzing Apoptosis

              Citas

              Título
            • Joao B. Oliveira, et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Procedings of the National Academy of Science 104, 8953-8958.
            • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
            • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
              		•
              Ficha técnica

              Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

              Revision17-July-2014 JSW
              SynonymsMLCK Inhibitor I, PKA Inhibitor II
              DescriptionA potent, cell-permeable, reversible, ATP-competitive and broad spectrum inhibitor of protein kinases. Inhibits CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase A (IC50 = 7 nM), protein kinase C (IC50 = 0.7 nM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint.
              FormWhite to pale yellow solid
              Intert gas (Yes/No) Packaged under inert gas
              CAS number62996-74-1
              Chemical formulaC₂₈H₂₆N₄O₃
              Structure formulaStructure formula
              Purity≥99% by HPLC
              SolubilityDMSO (5 mg/ml). Further dilute with aqueous buffers just prior to use.
              Storage Protect from light
              +2°C to +8°C
              Do Not Freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-70°C). Stock solutions are stable for up to 6 months at -70°C.
              Toxicity Standard Handling
              ReferencesCouldwell, W.T., et al. 1994. FEBS Lett. 345, 43.
              Nishimura, H. and Simpson, I.A. 1994. Biochem. J. 302, 271.
              Bruno, S., et al. 1992. Cancer Res. 52, 470.
              Kiss, Z. and Deli, E. 1992. Biochem. J. 288, 853.
              Vitale, M.L., et al. 1992. Neuroscience 51, 463.
              Hoffman, R. and Newland, E.S. 1991. Cancer Chemother. Pharmacol. 28, 102.
              Oka, S., et al. 1986. Agric. Biol. Chem. 50, 2723.
              Citation
            • Joao B. Oliveira, et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Procedings of the National Academy of Science 104, 8953-8958.
            • Siva Kumar Kolluri, et al. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Procedings of the National Academy of Science 102, 2525-2530.
            • Rick B. Vega, et al. (2004) Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5. Molecular and Cellular Biology 24, 8374-8385.
              		•

              Productos y aplicaciones relacionados

              Categorías

              Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase C (PKC) Inhibitors
              Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase A (PKA; cAMP-Dependent Protein Kinase) Inhibitors
              Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase G (PKG; cGMP-Dependent Protein Kinase) Inhibitors